TRPM3 and miR-204 Establish a Regulatory Circuit that Controls Oncogenic Autophagy in Clear Cell Renal Cell Carcinoma

被引:217
作者
Hall, Daniel P. [1 ]
Cost, Nicholas G. [1 ,5 ]
Hegde, Shailaja [1 ]
Kellner, Emily [1 ]
Mikhaylova, Olga [1 ]
Stratton, Yiwen [1 ]
Ehmer, Birgit [1 ]
Abplanalp, William A. [1 ]
Pandey, Raghav [1 ]
Biesiada, Jacek [4 ]
Harteneck, Christian [6 ,7 ]
Plas, David R. [1 ]
Meller, Jarek [3 ,4 ,8 ]
Czyzyk-Krzeska, Maria F. [1 ,2 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45267 USA
[2] VA Res Serv, Dept Vet Affairs, Cincinnati, OH 45220 USA
[3] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA
[4] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA
[5] Cincinnati Childrens Hosp Med Ctr, Div Pediat Urol, Cincinnati, OH 45229 USA
[6] Univ Tubingen, Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany
[7] Univ Tubingen, Interfac Ctr Pharmacogen & Drug Res, D-72074 Tubingen, Germany
[8] Nicolas Copernicus Univ, Dept Informat, PL-87100 Torun, Poland
关键词
HORMONE-RELATED PROTEIN; KINASE KINASE-BETA; RNA-POLYMERASE-II; DIFFERENTIAL EXPRESSION; GROWTH-FACTOR; TUMOR-GROWTH; CAVEOLIN-1; CHANNELS; SURVIVAL; PATHWAY;
D O I
10.1016/j.ccell.2014.09.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Autophagy promotes tumor growth by generating nutrients from the degradation of intracellular structures. Here we establish, using shRNAs, a dominant-negative mutant, and a pharmacologic inhibitor, mefenamic acid (MFA), that the Transient Receptor Potential Melastatin 3 (TRPM3) channel promotes the growth of clear cell renal cell carcinoma (ccRCC) and stimulates MAP1LC3A (LC3A) and MAP1LC3B (LC3B) autophagy. Increased expression of TRPM3 in RCC leads to Ca2+ influx, activation of CAMKK2, AMPK, and ULK1, and phagophore formation. In addition, TRPM3 Ca2+ and Zn2+ fluxes inhibit miR-214, which directly targets LC3A and LC3B. The von Hippel-Lindau tumor suppressor (VHL) represses TRPM3 directly through miR-204 and indirectly through another miR-204 target, Caveolin 1 (CAV1).
引用
收藏
页码:738 / 753
页数:16
相关论文
共 55 条
[1]
MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death [J].
Aurora, Arin B. ;
Mahmoud, Ahmed I. ;
Luo, Xiang ;
Johnson, Brett A. ;
van Rooij, Eva ;
Matsuzaki, Satoshi ;
Humphries, Kenneth M. ;
Hill, Joseph A. ;
Bassel-Duby, Rhonda ;
Sadek, Hesham A. ;
Olson, Eric N. .
JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (04) :1222-1232
[2]
Gene autoregulation via intronic microRNAs and its functions [J].
Bosia, Carla ;
Osella, Matteo ;
El Baroudi, Mariama ;
Cora, Davide ;
Caselle, Michele .
BMC SYSTEMS BIOLOGY, 2012, 6
[3]
Targeting TRP channels for pain relief [J].
Brederson, Jill-Desiree ;
Kym, Philip R. ;
Szallasi, Arpad .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 716 (1-3) :61-76
[4]
PARATHYROID-HORMONE RELATED PEPTIDE CAN FUNCTION AS AN AUTOCRINE GROWTH-FACTOR IN HUMAN RENAL-CELL CARCINOMA [J].
BURTON, PBJ ;
MONIZ, C ;
KNIGHT, DE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 167 (03) :1134-1138
[5]
Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma [J].
Campbell, L. ;
Jasani, B. ;
Edwards, K. ;
Gumbleton, M. ;
Griffiths, D. F. R. .
BRITISH JOURNAL OF CANCER, 2008, 98 (05) :931-940
[6]
Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis [J].
Chow, Tsz-Fung F. ;
Youssef, Youssef M. ;
Lianidou, Evi ;
Romaschin, Alexander D. ;
Honey, R. John ;
Stewart, Robert ;
Pace, Kenneth T. ;
Yousef, George M. .
CLINICAL BIOCHEMISTRY, 2010, 43 (1-2) :150-158
[7]
Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer [J].
Connolly, EM ;
Harmey, JH ;
O'Grady, T ;
Foley, D ;
Roche-Nagle, G ;
Kay, E ;
Bouchier-Hayes, DJ .
BRITISH JOURNAL OF CANCER, 2002, 87 (02) :231-237
[8]
Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials [J].
Coppin, Chris ;
Kollmannsberger, Christian ;
Le, Lyly ;
Porzsolt, Franz ;
Wilt, Timothy J. .
BJU INTERNATIONAL, 2011, 108 (10) :1556-1563
[9]
Comprehensivemolecular characterization of clear cell renal cell carcinoma [J].
Creighton, Chad J. ;
Morgan, Margaret ;
Gunaratne, Preethi H. ;
Wheeler, David A. ;
Gibbs, Richard A. ;
Robertson, A. Gordon ;
Chu, Andy ;
Beroukhim, Rameen ;
Cibulskis, Kristian ;
Signoretti, Sabina ;
Vandin, Fabio ;
Wu, Hsin-Ta ;
Raphael, Benjamin J. ;
Verhaak, Roel G. W. ;
Tamboli, Pheroze ;
Torres-Garcia, Wandaliz ;
Akbani, Rehan ;
Weinstein, John N. ;
Reuter, Victor ;
Hsieh, James J. ;
Brannon, A. Rose ;
Hakimi, A. Ari ;
Jacobsen, Anders ;
Ciriello, Giovanni ;
Reva, Boris ;
Ricketts, Christopher J. ;
Linehan, W. Marston ;
Stuart, Joshua M. ;
Rathmell, W. Kimryn ;
Shen, Hui ;
Laird, Peter W. ;
Muzny, Donna ;
Davis, Caleb ;
Morgan, Margaret ;
Xi, Liu ;
Chang, Kyle ;
Kakkar, Nipun ;
Trevino, Lisa R. ;
Benton, Susan ;
Reid, Jeffrey G. ;
Morton, Donna ;
Doddapaneni, Harsha ;
Han, Yi ;
Lewis, Lora ;
Dinh, Huyen ;
Kovar, Christie ;
Zhu, Yiming ;
Santibanez, Jireh ;
Wang, Min ;
Hale, Walker .
NATURE, 2013, 499 (7456) :43-+
[10]
von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR [J].
Danilin, Sabrina ;
Sourbier, Carole ;
Thomas, Lionel ;
Rothhut, Sylvie ;
Lindner, Veronique ;
Helwig, Jean-Jacques ;
Jacqmin, Didier ;
Lang, Herve ;
Massfelder, Thierry .
CARCINOGENESIS, 2009, 30 (03) :387-396